Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125037842 | 12503784 | 2 | F | 20160522 | 20160622 | 20160628 | 20160701 | EXP | GB-TEVA-670036ACC | TEVA | 46.00 | YR | M | Y | 70.60000 | KG | 20160701 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125037842 | 12503784 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | Intravenous (not otherwise specified) | ON DAY ONE OF 21 DAY CYCLE | Y | U | 74656 | 80 | MG/M**2 | ||||||
| 125037842 | 12503784 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Y | U | 74656 | ||||||||||
| 125037842 | 12503784 | 3 | SS | XELODA | CAPECITABINE | 1 | Oral | 2268000 | MG/M2 | Y | U | 0 | 1000 | MG/M**2 | BID | ||||
| 125037842 | 12503784 | 4 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 0 | |||||||||||
| 125037842 | 12503784 | 5 | C | CYCLIZINE | CYCLIZINE | 1 | 0 | ||||||||||||
| 125037842 | 12503784 | 6 | C | NUTRITIONAL SUPPLEMENT | DIETARY SUPPLEMENT | 1 | Unknown | 0 | |||||||||||
| 125037842 | 12503784 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 0 | |||||||||||
| 125037842 | 12503784 | 8 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | |||||||||||
| 125037842 | 12503784 | 9 | C | MEGACE | MEGESTROL ACETATE | 1 | Unknown | 0 | |||||||||||
| 125037842 | 12503784 | 10 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | 0 | |||||||||||
| 125037842 | 12503784 | 11 | C | ONDANSETRON | ONDANSETRON | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125037842 | 12503784 | 1 | Oesophageal adenocarcinoma |
| 125037842 | 12503784 | 3 | Oesophageal adenocarcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125037842 | 12503784 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125037842 | 12503784 | Constipation | |
| 125037842 | 12503784 | Dehydration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125037842 | 12503784 | 1 | 20130415 | 0 | ||
| 125037842 | 12503784 | 2 | 20160603 | 0 | ||
| 125037842 | 12503784 | 3 | 20130415 | 0 | ||
| 125037842 | 12503784 | 4 | 201601 | 0 | ||
| 125037842 | 12503784 | 6 | 20160421 | 0 | ||
| 125037842 | 12503784 | 7 | 201601 | 0 | ||
| 125037842 | 12503784 | 8 | 2010 | 0 | ||
| 125037842 | 12503784 | 9 | 20160415 | 0 | ||
| 125037842 | 12503784 | 10 | 20160414 | 0 | ||
| 125037842 | 12503784 | 11 | 20160415 | 20160523 | 0 |